|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 435.65 USD | -1.37% |
|
-2.49% | -3.91% |
| Capitalization | 111B 94.1B 86.88B 81.91B 152B 10,311B 155B 1,018B 399B 4,960B 416B 407B 17,638B | P/E ratio 2026 * |
24.9x | P/E ratio 2027 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise value | 97.71B 82.98B 76.61B 72.23B 134B 9,092B 136B 898B 352B 4,374B 367B 359B 15,553B | EV / Sales 2026 * |
7.5x | EV / Sales 2027 * | 6.5x |
| Free-Float |
99.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -1.37% | ||
| 1 week | -2.49% | ||
| Current month | -2.44% | ||
| 1 month | -6.53% | ||
| 3 months | -1.29% | ||
| 6 months | +6.62% | ||
| Current year | -3.91% |
| 1 week | 431.15 |  | 447.82 |
| 1 month | 425.26 | | 463.96 |
| Current year | 425.26 | | 507.92 |
| 1 year | 362.5 | | 510.77 |
| 3 years | 316.43 | | 519.88 |
| 5 years | 176.36 | | 519.88 |
| 10 years | 71.46 | | 519.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 10/04/2019 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -2.49% | -10.34% | +30.62% | 111B | |
| -0.11% | -5.36% | +23.01% | +141.24% | 809B | |
| -1.73% | -2.81% | +52.39% | +41.43% | 565B | |
| +0.27% | -1.61% | +21.73% | +29.33% | 370B | |
| -0.30% | -0.35% | +24.06% | +13.94% | 320B | |
| +0.03% | -2.47% | +46.72% | +25.63% | 312B | |
| -2.07% | -5.89% | +51.01% | +0.13% | 285B | |
| +0.12% | -3.55% | +29.58% | +33.30% | 286B | |
| +0.34% | -1.75% | +23.62% | +39.76% | 189B | |
| -0.21% | +6.44% | -34.32% | -55.97% | 180B | |
| Average | +0.33% | -1.72% | +22.75% | +29.94% | 342.52B | |
| Weighted average by Cap. | +0.71% | -2.44% | +28.80% | +50.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.02B 11.06B 10.21B 9.63B 17.86B 1,212B 18.17B 120B 46.91B 583B 48.86B 47.84B 2,073B | 14.36B 12.19B 11.26B 10.61B 19.68B 1,336B 20.03B 132B 51.7B 643B 53.85B 52.73B 2,285B |
| Net income | 4.5B 3.82B 3.53B 3.32B 6.17B 418B 6.27B 41.33B 16.2B 201B 16.87B 16.52B 716B | 5.17B 4.39B 4.05B 3.82B 7.09B 481B 7.21B 47.51B 18.62B 231B 19.39B 18.99B 823B |
| Net Debt | -13.1B -11.12B -10.27B -9.68B -17.96B -1,219B -18.28B -120B -47.18B -586B -49.14B -48.12B -2,085B | -17.51B -14.87B -13.73B -12.94B -24.01B -1,629B -24.43B -161B -63.06B -784B -65.68B -64.31B -2,787B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/04/26 | 435.65 $ | -1.37% | 1,364,285 |
| 15/04/26 | 441.70 $ | -0.58% | 1,459,489 |
| 14/04/26 | 444.28 $ | +0.96% | 1,445,501 |
| 13/04/26 | 440.05 $ | +0.87% | 1,004,739 |
| 10/04/26 | 436.27 $ | -2.35% | 985,779 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition